Education
About Us
Working with TipRanks
Follow Us
Editas Medicine Inc. (CH:8EM)
:8EM
Total Valuation
Editas Medicine has a market cap or net worth of ―. The enterprise value is ―.
Market Cap―
Enterprise Value―
Share Statistics
Editas Medicine has ― shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding―
Owned by Insiders0.82%
Owned by Institutions6.53%
Financial Efficiency
Editas Medicine’s return on equity (ROE) is -1.77 and return on invested capital (ROIC) is -90.01%.
Return on Equity (ROE)-1.77
Return on Assets (ROA)-0.69
Return on Invested Capital (ROIC)-90.01%
Return on Capital Employed (ROCE)-0.95
Revenue Per Employee131.36K
Profits Per Employee-963.79K
Employee Count246
Asset Turnover0.09
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Editas Medicine is -0.44. Editas Medicine’s PEG ratio is -0.01.
PE Ratio-0.44
PS Ratio―
PB Ratio0.78
Price to Fair Value0.78
Price to FCF-0.48
Price to Operating Cash Flow-0.50
PEG Ratio-0.01
Income Statement
In the last 12 months, Editas Medicine had revenue of 32.31M and earned -237.09M in profits. Earnings per share was -2.88.
Revenue32.31M
Gross Profit32.31M
Operating Income-251.15M
Pretax Income-237.09M
Net Income-237.09M
EBITDA-233.11M
Earnings Per Share (EPS)-2.88
Cash Flow
In the last 12 months, operating cash flow was -210.28M and capital expenditures -8.83M, giving a free cash flow of -219.11M billion.
Operating Cash Flow-210.28M
Free Cash Flow-219.11M
Free Cash Flow per Share―
Dividends & Yields
Editas Medicine pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta―
52-Week Price Change―
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)―
Important Dates
Editas Medicine upcoming earnings date is May 12, 2025, TBA Not Confirmed.
Last Earnings DateMar 5, 2025
Next Earnings DateMay 12, 2025
Ex-Dividend Date―
Financial Position
Editas Medicine as a current ratio of 3.75, with Debt / Equity ratio of 26.09%
Current Ratio3.75
Quick Ratio3.75
Debt to Market Cap0.34
Net Debt to EBITDA0.41
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Editas Medicine has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Editas Medicine EV to EBITDA ratio is -0.03, with an EV/FCF ratio of -0.04.
EV to Sales0.25
EV to EBITDA-0.03
EV to Free Cash Flow-0.04
EV to Operating Cash Flow-0.04
Balance Sheet
Editas Medicine has $269.91M in cash and marketable securities with $411.00K in debt, giving a net cash position of -$234.88M billion.
Cash & Marketable Securities$269.91M
Total Debt$411.00K
Net Cash-$234.88M
Net Cash Per Share―
Tangible Book Value Per Share$1.63
Margins
Gross margin is 86.30%, with operating margin of -777.22%, and net profit margin of -733.72%.
Gross Margin86.30%
Operating Margin-777.22%
Pretax Margin-733.72%
Net Profit Margin-733.72%
EBITDA Margin-721.39%
EBIT Margin-739.37%
Analyst Forecast
The average price target for Editas Medicine is $2.58, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$2.58
Price Target Upside― Downside
Analyst ConsensusModerate Buy
Analyst Count10
Revenue Growth Forecast―
EPS Growth Forecast―